LH · 10-Q · 2026Q3 · Full report
Operating Expense Trends
LABCORP HOLDINGS INC. · 2026-10-30 · Importance 29 · Surprise 22 · No source text
Third-quarter SG&A increased 10.5% to $611.4 million, and rose to 16.0% of revenue from 15.5%, primarily due to higher personnel costs and LaunchPad costs, partly offset by revenue growth. Nine-month SG&A increased 3.6% to $1,739.6 million, but declined to 15.7% of revenue from 16.1% as revenue grew. Amortization of intangibles and other assets increased 13.3% to $78.7 million in the quarter and 12.1% to $232.4 million in the nine-month period, reflecting additional amortization on assets acquired after September 30, 2025. General corporate and unallocated expenses rose 39.3% to $153.9 million in the quarter, primarily from higher LaunchPad and acquisition- and disposition-related costs.
Key facts
- Labcorp SG&A was $611.4 million in the three months ended September 30, 2026, up 10.5%; SG&A was 16.0% of revenues versus 15.5%, driven primarily by increased personnel costs and higher LaunchPad initiative costs, partly offset by revenue growth. source
- Labcorp SG&A was $1,739.6 million in the nine months ended September 30, 2026, up 3.6%; SG&A was 15.7% of revenues versus 16.1%, with the decline primarily due to revenue growth. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | realized | -1.6% | Labcorp SG&A was $1,739.6 million in the nine months ended September 30, 2026, up 3.6%; SG&A was 15.7% of revenues versus 16.1%, with the… |
| margin | positive | realized | +0.4% | Labcorp SG&A was $1,739.6 million in the nine months ended September 30, 2026, up 3.6%; SG&A was 15.7% of revenues versus 16.1%, with the… |